Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LIPriorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med.2006;31(1):52-61.
2.
Maciosek MV, Edwards NM, Coffield AB, et al. Priorities among effective clinical preventive services: methods . Am J Prev Med.2006;31(1):90-96.
3.
Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJColorectal cancer screening: health impact and cost effectiveness. Am J Prev Med.2006;31(1):80-89.
4.
Seef LC, King J., Pollack LA, Williams KNIncreased use of colorectal cancer tests—United States, 2002 and 2004 . MMWR. March 2006. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5511a4.htm. Accessed July 18, 2006.
5.
National Center for Chronic Disease Prevention & Health Promotion. Prevalence Data. Colorectal Cancer Screening2004. Behavioral Risk Factor Surveillance System. Centers for Disease Control and Prevention. Available at: http://Apps.nccd.cdc.gov/brfss/. Accessed July 18, 2006.
6.
Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093-2103.
7.
Shih YT, Zhao L., Elting LSDoes Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly?Health Aff.2006:25(4):1153-1163.
8.
National Committee for Quality Assurance.Colorectal Cancer Screening. The State of Health Care Quality 2006. Washington, DC. Available at: http://www.NCQA.org/Communications/SOHC2006/SOHC_2006.pdf (page 31). Accessed October 5, 2006.
9.
Winawer SJ, Flehinger BJ, Schottenfeld D., Miller DGScreening for colorectal cancer with fecal occult blood testing and sigmoidoscopy . J Natl Cancer Inst. 1993;85(23):1965-1966.
10.
Lieberman DA , Weiss DGOne time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med.2001;345:555-560.
11.
Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet.1996 ;348:1472-1477.
12.
Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med.1993;329:1977-1981.
13.
National Cancer Institute.Conquering Colorectal Cancer: A Blueprint for the Future—The Report of the Colorectal Cancer Progress Review Group. Bethesda, MD: National Cancer Institute; 2000 .
14.
Levin B., Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer. 2002 :95(8): 1618-1628.
15.
Centers for Disease Control and Prevention.Comprehensive Cancer Control Plans: A content review. December 2005. Available at: http://www.cdc.gov/cancer/ncccp/cccpdf/CCC_Plans_Content_Rev.pdf. Accessed December 2, 2006.
16.
Fletcher RH , Colditz GA, Pawlson LG, Richman H., Rosenthal D., Salber PRScreening for colorectal cancer: the business case. Am J Manag Care.2002;8:531-538.
17.
U.S. Preventive Services Task Force.Screening for colorectal cancer: recommendations and rationale. Ann Inter Med.2002; 137(2):129-131
18.
Winawer S., Fletcher R., Rex D., et al for the Multisociety Task Force on Colorectal Cancer. American Gastroenterological Association: colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology . 2003;124:544-560.
19.
Smith RA, Cokkinides V., Eyre HJAmerican Cancer Society guidelines for the early detection of cancer, 2003 . CA Cancer J Clin. 2003;53(1):27-43.
20.
Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and the American Gastroenterological Association.2004Colorectal Cancer Legislation Report Card. Available at: http://www.eifoundation.org/national/nccra/report_card/.
21.
Grady KE, Lemkau JP, McVay JM, Reisine STThe importance of physician encouragement in breast cancer screening of older women. Prev Med.1992;21:776-780.
22.
Brown CLScreening patterns for cervical cancer: how best to reach the unscreened population . J Natl Cancer Inst Monogr. 1996;(21):7-11. Review.
23.
Fox SA, Stein JAThe effect of physician-patient communication on mammography utilization by different ethnic groups. Med Care (Phila).1991;29:1065-1082.
24.
Taylor V., Lessler D., Mertens K., et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc.2003;95(9): 806-812.
25.
Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093-2103.
26.
O'Malley MS , Earp JA, Hawley ST, Schell MJ, Mathews HF, Mitchell J.The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening?Am J Public Health.2001;91(1):49-54.
27.
Hawley ST, Earp JA, O'Malley M., Ricketts TCThe role of physician recommendation in women's mammography use: is it a 2 stage process?Med Care.2000;38(4):392-403.
28.
Devoe JE, Fryer GE, Phillips R., Green L.Receipt of preventive care among adults: insurance status and usual source of care. Am J Pub Health. 2003;93:786-791.
29.
Bindman AB, Grumbach K., Osmond D., Vranizan K., Stewart ALPrimary care and receipt of preventive services. J Gen Intern Med.1996;11:269-276.
30.
Wender RCBarriers to screening for colorectal cancer. Gastrointest Endosc Clin N Am.2002; 12(l):145-170.
31.
Zapka JG, Puleo E., Vickers-Lahti M., Luckmann R.Healthcare system factors and colorectal cancer screening. Am J Prev Med.2002;23(1):28-35.
32.
Harokopos V., McDermott RJCervical cancer screening: benefits and barriers. J Health Educ. 1996;27(6):351-356.
33.
Marcus AC, Crane LAA review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med.1998;27(1):13-31. Review
34.
Yamamoto M., Nakamata H.Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology . 2000;47:396-399.
35.
Sharma VK, Corder FA, Fancher J., Howden CWSurvey of the opinions, knowledge, and practices of gastroenterologists regarding colorectl cancer screening and use of the fecal occult blood test. Am J Gastroenterol.2000;95:3629-3632.
36.
Lurie JD, Welch HGDiagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst.1999; 91:1641-1646.
37.
Klabunde CN , Frame PS, Meadow A., Jones E., Nadel M., Vernon SWA national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med.2003;36(3):352-362.
